The importance of IL-6 protein expression in primary human renal cell carcinoma: an immunohistochemical study

被引:25
作者
Paule, B
Belot, J
Rudant, C
Coulombel, C
Abbou, CC
机构
[1] CNRS, UPR 37, REgulat Express Genes, UFR Biomed, F-75006 Paris, France
[2] Hop Henri Mondor, Serv Urol, F-94010 Creteil, France
[3] Hop Henri Mondor, Serv Anatomopathol, F-94010 Creteil, France
关键词
interleukin; 6; renal cell carcinoma; immunohistochemistry;
D O I
10.1136/jcp.53.5.388
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-Interleukin 6 (IL-6) is produced by some renal carcinoma cell lines in vitro. This might be biologically important because IL-6 is a cytokine of particular interest, owing to its involvement in the growth of renal cell carcinoma. In this study, the expression of IL-6 protein in tissue samples from primary renal cell carcinoma was analysed, and then its clinical importance was examined. Methods-The distribution of IL-6 in renal cell carcinoma was examined by means of an immunohistochemical method in 47 untreated primary renal cell carcinoma samples. The search for a significant difference between histological patterns, Furhman's grading system, TNM classification, and IL-6 protein expression was carried out. Results-Immunohistochemistry demonstrated that IL-6 is expressed in 70% of primary tumours. There was no significant difference in the tumour size and grade between renal cell carcinomas with or without IL-6 expression. However, a relatively large number of high grade tumours expressed IL-6. Conclusion-The importance of IL-6 expression with regard to tumour size/local growth is questionable because IL-6 has been correlated with the development of metastatic disease. These data suggest that the production of IL-6 could exert a growth inhibitory effect on primary renal cell carcinoma.
引用
收藏
页码:388 / 390
页数:3
相关论文
共 15 条
[1]  
BLAY JY, 1992, CANCER RES, V52, P3317
[2]  
BLAY JY, 1994, P AM ASS CLIN RES, V35, P3557
[3]   Expression of the interleukin 6 receptor in primary renal cell carcinoma [J].
Costes, V ;
Liautard, J ;
Picot, MC ;
Robert, M ;
Lequeux, N ;
Brochier, J ;
Baldet, P ;
Rossi, JF .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (10) :835-840
[4]  
FURHMAN SA, 1982, AM J SURG PATHOL, V6, P655
[5]   INTERLEUKIN-6 AND RENAL-CELL CANCER - PRODUCTION, REGULATION, AND GROWTH EFFECTS [J].
KOO, AS ;
ARMSTRONG, C ;
BOCHNER, B ;
SHIMABUKURO, T ;
TSO, CL ;
DEKERNION, JB ;
BELLDEGRUN, A .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 35 (02) :97-105
[6]  
KOO AS, 1990, SURG FORUM, V41, P710
[7]  
LAGNEAUX L, 1993, BLOOD, V82, P2379
[8]  
LOTEM J, 1992, BLOOD, V80, P1750
[9]   INTERLEUKIN-6 - A FIBROBLAST-DERIVED GROWTH INHIBITOR OF HUMAN-MELANOMA CELLS FROM EARLY BUT NOT ADVANCED STAGES OF TUMOR PROGRESSION [J].
LU, C ;
VICKERS, MF ;
KERBEL, RS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9215-9219
[10]   INTERLEUKIN-6 (IL-6) FUNCTIONS AS AN INVITRO AUTOCRINE GROWTH-FACTOR IN RENAL-CELL CARCINOMAS [J].
MIKI, S ;
IWANO, M ;
MIKI, Y ;
YAMAMOTO, M ;
TANG, B ;
YOKOKAWA, K ;
SONODA, T ;
HIRANO, T ;
KISHIMOTO, T .
FEBS LETTERS, 1989, 250 (02) :607-610